4//SEC Filing
Sullivan Lara 4
Accession 0001567619-22-008613
CIK 0001782223other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:56 PM ET
Size
5.4 KB
Accession
0001567619-22-008613
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Award
Common Stock
2022-04-14+315,273→ 1,356,636 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") that vest on April 13, 2023, subject to the Reporting Person's continued employment through the vesting date.
- [F2]The Compensation Committee also approved a grant to the Reporting Person, effective January 3, 2023, of an additional 95,684 RSUs that vest on April 13, 2023, subject to the Reporting Person's continued employment through the grant and vesting dates.
- [F3]The Compensation Committee also approved a grant to the Reporting Person of $200,000 cash compensation that is payable in full on April 13, 2023, subject to the Reporting Person's continued employment through the payment date.
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001769457
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 7:56 PM ET
- Size
- 5.4 KB